Business
CEO Video Interview with Medworxx Inc: A fast growing Healthcare IT player with a blue chip customer base
CEO Video Interview with Medworxx Inc: A fast growing Healthcare IT player with a blue chip custo...

About this update from Regenx Tech Corp
[{"type":"text","content":"\nCEO Video Interview with Medworxx Inc: A fast growing Healthcare IT player with a blue chip customer base\n\n\n Nov. 11, 2010 (Baystreet.ca) -- TORONTO, Canada - Ubika Research has released a CEO video interview with Mr. Dan Matlow, President & CEO of Medworxx Inc (TSX VENTURE: MWX) (CVE: MWX). To view our CEO video interview with Medworxx President & CEO, Mr. Dan Matlow, please visit: http://www.smallcappower.com/microsite/medworxx_solutions_inc_videos.html Medworxx is the leader in the growing field of patient flow products within the fast growing health care IT sector. Patient flow has emerged as a key area of focus in hospitals as countries grapple with spiraling healthcare costs, lack of enough hospital beds and the pressures of an ageing population with complex needs. Medworxx has over 120 hospitals as its customers. In this interview, Mr. Matlow discusses Medworxx’s plan to grow both in Canada, US and internationally leveraging its leadership in this emerging growth area. Ubika Research believes that there are very few small cap publicly traded health care IT companies in Canada with real revenues and a solid blue chip customer base in health care vertical. Other than Medworxx, QHR Technologies (TSXV: QHR) (CVE: QHR) and ZoomMed Inc (TSXV: ZMD) (CVE: ZMD) are among the few other publicly listed health care IT companies in Canada that we are aware for investors to get exposure to healthcare IT in the small cap space. Download the research reports on Medworxx at: http://www.smallcappower.com/microsite/medworxx_solutions_inc_research_reports.html About Ubika ResearchUbika Research is an investment research and capital market services firm based in Toronto and Vancouver. It provides comprehensive research, communication and capital market exposure program to highlight the investment potential in micro and small cap companies. For more information visit ubikaresearch.com DisclosureExcept for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.Ubika Research, a division of Ubika Corporation, is not registered with any financial or securities regulatory authority,...